StockWatch
·

Lyell Immunopharma, Inc.

Ticker: 1806952

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
0.00
-100.0%
Expenditure
48.30
+2.0%+29.6%
Net Profit
-45.53
-1.7%-17.2%
OPM %
-100.00%

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-75.04-37.92-0.8136.3173.43Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News